Lysolecithin Market - Forecast(2024 - 2030)

Overview

The lysolecithin market size is forecast to reach USD 232.57 million by 2031, after growing at a CAGR of 5.72% during 2024-2031. The expansion is ascribed to the potential applications in the life science sector, such as in medicine, and biotechnology. For instance, in November 2020, one of the Global biotech innovators, Aker BioMarine launched LYSOVETA™, a new delivery platform based on LPC-bound EPA and DHA from krill. This is an important breakthrough that will create new opportunities and large markets in the brain, eye, and other critical areas of health. Lysolecithin is also used as an emulsifier and stabilizer in the food and beverage sector. The demand for processed meals and convenience goods has increased, which has resulted in a greater demand for lysolecithin which enhances product texture, shelf life, and overall quality.

Report Coverage :

The report “Lysolecithin Market– Forecast (2024-2031)”, by IndustryARC, covers an in-depth analysis of the following segments of the lysolecithin market.

By Source: Egg, Soy, Rapeseed, Others

By Type: Hydrolyzed Lysolecithin, Chemically Modified Lysolecithin, Others

By Product Type: Powdered Lysolecithin, Liquid Lysolecithin

By Grade: Food Grade, Pharmaceutical Grade, Commercial Grade, Others

By Application: Food and Beverage, Pharmaceutical, Cosmetics & Personal Care, Industrial, Animal Feed, Others 

By Geography:  North America, Asia-Pacific, Europe, South America, ROW

Key Takeaways

• The continuous growth and innovation of technology that enables discoveries, and solutions in the life sciences industry is driving the market for Egg lysolecithin. Because of its natural origin and good features for skin and hair care products, the egg lysolecithin market is expected to gain attention in the cosmetic business.
• The rising incidences of lifestyle-based health issues, such as obesity, and diabetes, have fuelled consumers' need for lysolecithins in food supplements. For instance, the IDF Diabetes Atlas 2021 reports that 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware that they are living with the condition. According to IDF predictions, 783 million adults, or one in eight, would have diabetes by 2045, a 46% rise.
• As a result of the pharmaceutical industry's continued R&D in drug delivery systems, the United States is the dominant country in the lysolecithin market. The demand for specialized excipients such as lysolecithin is increasing as pharmaceutical companies in the U.S seek new ways to improve patient outcomes and treatment efficacy.

By Product - Segment Analysis

Egg lysolecithin dominated the lysolecithin market in 2023. Egg lysolecithin is used in a variety of cosmetic goods as a moisturizer, emollient, and anti-aging agent, including creams, lotions, shampoos, conditioners, and lipsticks. Because of its natural origin and good features for skin and hair care products, the egg lysolecithin market is expected to gain attention in the cosmetic business. For instance, according to the Cosmetics Europe Association, the market penetration of some cosmetic and personal care goods in the EU is expected to be close to 100%. For example, in France, 98% of adult women and 94% of adult men use liquid shampoo.

By Application - Segment Analysis

Pharmaceutical applications dominated the lysolecithin market in 2023. The pharmaceutical industry is constantly looking for cutting-edge drug delivery systems to improve patient compliance, deal with medications more effectively, and improve therapeutic results. Interest in using lysolecithin as an excipient in various drug delivery systems has increased due to its special qualities and possible advantages.

For instance, according to a recent analysis published in Global Use of Medicines 2023 - Outlook through 2027 from the IQVIA Institute for Human Data Science, total spending and global demand for pharmaceuticals will rise over the next four years to nearly $1.9 trillion by 2027. Despite efforts by payers to limit their budgets and the impact of less expensive options, the underlying growth rate of spending will be between 3 and 6 percent and will be driven by the introduction of new drugs and increased use of newly launched brands.

By Geography - Segment Analysis

North America's lysolecithin market dominated the geography segment in 2023 as a result of the pharmaceutical industry's ongoing research and development in drug delivery methods.  For instance, in a recent study that was published in Scientific Reports in June 2023 by Sigmovir Biosystems, Inc., and the University of British Columbia Canada, Researchers assessed the effects of dietary lysophosphatidylcholine (LPC), which is made up of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on retinal function in Alzheimer's disease (AD)-associated retinopathy. This research demonstrates that dietary lysophosphatidylcholine helps improve retinopathy brought on by Alzheimer's disease.

Drivers – Lysolecithin Market

• Rising Awareness of the Health Benefits of Lysolecithin : The major factor driving the market growth is the rising awareness of the health benefits of lysolecithin such as lowering cholesterol levels, improving cognitive function, and preventing liver damage. However, the evidence for these effects is not conclusive and more research is needed to confirm the safety and efficacy of other types of lysolecithins. The aging population in North America is also driving the demand for lysolecithin market for various dietary supplements that can help maintain and enhance overall health and well-being. For instance, according to the U.S. Department of Commerce, starting in 2030, when all boomers will be older than 65, older Americans will make up 21% of the population, up from 15 percent today.

• The Increased Demand for Bakery Items and Low-Fat Diets in Food Products : The increased demand for bakery items influences the use of lysolecithin emulsifiers. For example, it is used to increase the texture, volume, shelf life, and machinability of bakery items such as bread, cakes, and pastries. It also helps improve the browning and crust formation of baked goods. The growing popularity of low-fat diets in food products, such as the keto diet, is driving the expansion of the lysolecithin market. For instance, according to the American Bakers Association, the economic effect of baked products made and sold in the United States is $423 billion and at least 80% of consumers in America believe that baked goods are a vital component of family traditions, special occasions, and holidays.

Challenges – Lysolecithin Market

• The High Cost of Production and Extraction of Lysolecithin from Natural Sources :  Enzymatic hydrolysis, purification, and drying methods are used in the manufacture and extraction of lysolecithin from natural sources such as soy or sunflower seeds. These methods are expensive since they rely on enzymes for purification, as well as energy and labor. For example, a hydrolysis enzyme is required in the production of vegetable lysolecithin from hydrated lecithin. The lysolecithin market is hampered because these procedures necessitate cost-effective methodologies and technology to be economically viable.

Market Landscape

Technology launches, acquisitions, and R&D activities are key strategies adopted by players in the lysolecithin market. In 2023, the lysolecithin market share has been moderately consolidated by the major players accounting for 60.73% of the share. Major players in the lysolecithin market are Cargill, Inc., Cayman Chemical, Creative Biolabs, Nikko Chemicals, Kemin, Foodchem, Nippon Fine Chemical, DSM, American Lecithin Company and Giiava.

Developments:

Ø  In September 2022, Aker BioMarine and Trofi Nutritional Inc. established an agreement to create medical food products based on Lysoveta that will target gestational diabetes, Alzheimer's disease, and male infertility in addition to prenatal supplements in the U.S.

Ø  In July 2020, Croda International acquired Avanti Polar Lipids, Inc. Avanti's expertise in lipid-based delivery of drug solutions through its scientific products and drugs services, combined with Croda's range of life sciences products and cGMP manufacturing facilities, expands their respective breadth of services and products for biotechnology organizations, universities, and pharmaceutical companies worldwide.